AMGN vs REGN: Which Stock is Better?

Side-by-side comparison of Amgen Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

AMGN

Amgen Inc

$388.16

REGN

Regeneron Pharmaceuticals Inc

$781.67

Key Metrics Comparison

MetricAMGNREGNWinner
Market Cap$209.24B$82.64BAMGN
P/E Ratio27.2418.83REGN
EPS (TTM)$14.25$41.51REGN
Revenue Growth0.1%0.0%AMGN
Gross Margin70.8%44.6%AMGN

Analyze AMGN

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AMGN or REGN a better investment?

Comparing AMGN and REGN: Amgen Inc has a market cap of $209.24B while Regeneron Pharmaceuticals Inc has $82.64B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AMGN and REGN?

AMGN (Amgen Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AMGN or REGN?

Based on P/E ratios, REGN trades at a lower multiple (18.8x vs 27.2x).

Which is growing faster: AMGN or REGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for REGN.

Which company is more profitable: AMGN or REGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 44.6% for REGN.

Which is the larger company: AMGN or REGN?

Amgen Inc (AMGN) is larger with a market cap of $209.24B compared to $82.64B for REGN.

Should I buy AMGN or REGN in 2026?

Both AMGN and REGN have investment merit. AMGN trades at $388.16 while REGN trades at $781.67. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AMGN and REGN stock?

Key differences: Market Cap ($209.24B vs $82.64B), P/E Ratio (27.2x vs 18.8x), Revenue Growth (0.1% vs 0.0%), Gross Margin (70.8% vs 44.6%).

Popular Stock Comparisons